Dr. Ryan Reber, D.O

NPI: 1134352255
Total Payments
$90,073
2024 Payments
$7,353
Companies
43
Transactions
680
Medicare Patients
7,760
Medicare Billing
$930,374

Payment Breakdown by Category

Other$53,814 (59.7%)
Consulting$19,679 (21.8%)
Food & Beverage$13,127 (14.6%)
Travel$3,193 (3.5%)
Education$261.16 (0.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $53,814 41 59.7%
Consulting Fee $19,679 20 21.8%
Food and Beverage $13,127 582 14.6%
Travel and Lodging $3,193 31 3.5%
Education $261.16 6 0.3%

Top Paying Companies

Company Total Records Latest Year
Mylan Specialty L.P. $78,641 178 $0 (2024)
AstraZeneca Pharmaceuticals LP $3,106 146 $0 (2024)
GlaxoSmithKline, LLC. $1,579 96 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $1,256 51 $0 (2023)
Janssen Pharmaceuticals, Inc $979.84 35 $0 (2023)
Mylan Inc. $662.50 1 $0 (2021)
Philips Electronics North America Corporation $541.57 28 $0 (2023)
Insmed, Inc. $384.10 11 $0 (2023)
Regeneron Healthcare Solutions, Inc. $339.33 12 $0 (2024)
GENZYME CORPORATION $195.43 9 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $7,353 46 Mylan Specialty L.P. ($6,694)
2023 $11,779 66 Mylan Specialty L.P. ($10,580)
2022 $15,469 79 Mylan Specialty L.P. ($14,210)
2021 $8,322 94 Mylan Specialty L.P. ($6,033)
2020 $14,199 90 Mylan Specialty L.P. ($12,991)
2019 $29,782 148 Mylan Specialty L.P. ($27,996)
2018 $1,699 82 AstraZeneca Pharmaceuticals LP ($517.07)
2017 $1,471 75 AstraZeneca Pharmaceuticals LP ($339.87)

All Payment Transactions

680 individual payment records from CMS Open Payments — Page 1 of 28

Date Company Product Nature Form Amount Type
12/17/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $22.55 General
Category: RESPIRATORY
12/10/2024 Mylan Specialty L.P. YUPELRI (Drug) Food and Beverage In-kind items and services $7.68 General
Category: Anticholinergics, Inhaled
12/05/2024 Amgen Inc. TEZSPIRE (Biological) Food and Beverage In-kind items and services $14.75 General
Category: Inflammation
11/26/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $14.49 General
Category: RESPIRATORY
11/19/2024 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $22.29 General
Category: Respiratory
11/12/2024 Mylan Specialty L.P. YUPELRI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,862.88 General
Category: Anticholinergics, Inhaled
11/12/2024 Mylan Specialty L.P. YUPELRI (Drug) Travel and Lodging In-kind items and services $329.78 General
Category: Anticholinergics, Inhaled
11/12/2024 Mylan Specialty L.P. YUPELRI (Drug) Travel and Lodging Cash or cash equivalent $102.09 General
Category: Anticholinergics, Inhaled
11/12/2024 Electromed, Inc. SMARTVEST (Device) Food and Beverage Cash or cash equivalent $37.44 General
Category: HFCWO
11/11/2024 Mylan Specialty L.P. YUPELRI (Drug) Food and Beverage In-kind items and services $61.89 General
Category: Anticholinergics, Inhaled
11/05/2024 United Therapeutics Corporation TYVASO (Drug) Food and Beverage In-kind items and services $24.07 General
Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease
10/22/2024 AstraZeneca Pharmaceuticals LP TEZSPIRE (Biological) Food and Beverage In-kind items and services $17.31 General
Category: Respiratory
10/16/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $23.88 General
Category: RESPIRATORY
10/15/2024 PFIZER INC. ELIQUIS (Drug), PAXLOVID Food and Beverage In-kind items and services $22.88 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
10/14/2024 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Food and Beverage In-kind items and services $20.65 General
Category: Rare Disease
09/17/2024 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $13.62 General
Category: Respiratory
09/10/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $28.13 General
Category: Immunology
08/21/2024 Amgen Inc. TEZSPIRE (Biological) Food and Beverage In-kind items and services $32.11 General
Category: Inflammation
08/20/2024 Harmony Biosciences Llc WAKIX (Drug) Food and Beverage Cash or cash equivalent $6.52 General
Category: Narcoplepsy
08/07/2024 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $18.55 General
Category: Respiratory
08/05/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $16.27 General
Category: RESPIRATORY
07/25/2024 Mylan Specialty L.P. YUPELRI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $309.50 General
Category: Anticholinergics, Inhaled
07/19/2024 Mylan Specialty L.P. YUPELRI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $619.00 General
Category: Anticholinergics, Inhaled
07/11/2024 Mylan Specialty L.P. YUPELRI (Drug) Food and Beverage In-kind items and services $7.80 General
Category: Anticholinergics, Inhaled
07/08/2024 AstraZeneca Pharmaceuticals LP TEZSPIRE (Biological) Food and Beverage In-kind items and services $14.55 General
Category: Respiratory

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 19 2,353 2,954 $414,295 $223,627
2022 20 2,597 3,271 $462,095 $252,294
2021 16 1,415 2,073 $385,240 $234,076
2020 16 1,395 2,137 $376,096 $220,377
Total Patients
7,760
Total Services
10,435
Medicare Billing
$930,374
Procedure Codes
79

All Medicare Procedures & Services

79 procedure records from CMS Medicare Utilization — Page 4 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99406 Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes Office 2020 13 17 $340.00 $272.93 80.3%
99152 Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes Facility 2020 16 20 $1,400 $213.16 15.2%
94664 Demonstration and/or evaluation of patient use of aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure breathing (ippb) device Office 2020 13 14 $420.00 $205.54 48.9%
94010 Measurement and graphic recording of total and timed exhaled air capacity Facility 2020 15 15 $600.00 $93.83 15.6%

About Dr. Ryan Reber, D.O

Dr. Ryan Reber, D.O is a Internal Medicine healthcare provider based in Wynnewood, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2009. The National Provider Identifier (NPI) number assigned to this provider is 1134352255.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Reber, D.O has received a total of $90,073 in payments from pharmaceutical and medical device companies, with $7,353 received in 2024. These payments were reported across 680 transactions from 43 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($53,814).

As a Medicare-enrolled provider, Reber has provided services to 7,760 Medicare beneficiaries, totaling 10,435 services with total Medicare billing of $930,374. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Pulmonary Disease
  • Location Wynnewood, PA
  • Active Since 08/25/2009
  • Last Updated 09/14/2015
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1134352255

Products in Payments

  • Yupelri (Drug) $64,611
  • YUPELRI (Drug) $13,224
  • XARELTO (Drug) $979.84
  • BREZTRI (Drug) $700.05
  • TRELEGY ELLIPTA (Drug) $658.77
  • SYMBICORT (Drug) $644.69
  • FASENRA (Drug) $503.49
  • DUPIXENT (Biological) $500.01
  • BEVESPI AEROSPHERE (Drug) $495.56
  • FASENRA (Biological) $471.81
  • STIOLTO RESPIMAT (Drug) $457.36
  • NUCALA (Biological) $446.57
  • Arikayce (Drug) $384.10
  • OFEV (Drug) $303.84
  • (8874) inCourage (Device) $296.93
  • TEZSPIRE (Biological) $254.61
  • ANORO (Drug) $213.09
  • Xolair (Biological) $164.46
  • SPIRIVA RESPIMAT (Drug) $161.18
  • BREO (Drug) $150.46

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Wynnewood